LUMA Study
LUMA: Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants with Parkinson’s Disease The purpose of this study is to test an investigational drug called BIIB122 to see if it may slow the progression of PD. Key...